Blog: Research

Detailed Genetic Map Implicates Broad Immune Cell Involvement in MS, Reports Risk Variant in X Chromosome

3 October 2019

Source Multiple Sclerosis News Today: A new large-scale genetic map implicates broad immune system dysfunction in patients with multiple sclerosis (MS), suggests a key role of brain immune cells called microglia, and indicates an MS-related gene variant located in the X chromosome.

Altogether, the findings — the result of the largest reported study of MS to date — provide the basis for up to 48% of the heritability for this disease.

The study, “Multiple sclerosis genomic map...

A request from Kings College London

23 September 2019

Hello! I am a PhD Student at King’s College London, and my project is focused on investigating anxiety in Multiple Sclerosis.

European Committee for Treatment and Research In Multiple Sclerosis 2019

23 September 2019

Source MS Trust: The ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis) is the largest annual international conference devoted to basic and clinical research in multiple sclerosis. The 2019 meeting took place in Stockholm from 11 to 13 September.

NICE rejects Sativex in draft guidance on cannabis-based medicinal products

15 August 2019

Source MS Trust: Draft guidance published today on August 8 does not recommend Sativex as a treatment for MS spasticity because it is not a cost-effective treatment.

Grant from MS Society, Parkinson’s UK to Establish Digital Brain Bank

15 August 2019

Source Parkinson's News Today: The Multiple Sclerosis (MS) and Parkinson’s Tissue Bank at Imperial College London, is the largest repository of brain and spinal cord tissue samples in Europe.

Early MS scans 'can predict long-term prognosis'

30 July 2019

Source BBC: Scans carried out when someone is first diagnosed with multiple sclerosis can predict their long-term prognosis, research has shown.

MS: Drugs trial hope for multiple sclerosis patients

30 July 2019

Source BBC: Welsh patients are taking part in a drugs trial aimed at slowing late-stage multiple sclerosis progression.

Research request from Kings College London

30 July 2019

Source Kings College London: "I am a third-year psychology student at King’s College London, currently assisting a PhD student, Jowinn Chew (cc'd in this email), on her research supervised by Dr Colette Hirsch and Prof Rona Moss-Morris from the Health Psychology Department. The research is focusing on identifying the cognitive mechanisms which underpin and maintain anxiety surrounding illness uncertainty within MS.

Phase 1 Trial of T20K, Plant Protein-derived Therapy for MS, Doses 1st Group of Healthy Men

23 July 2019

Source Multiple Sclerosis News Today: A first group of healthy volunteers in a Phase 1 trial assessing the safety and tolerability of T20K, Cyxone‘s plant protein-derived candidate for the treatment of multiple sclerosis(MS), has been dosed in a study taking place in The Netherlands, the company announced.

Pages

Category

Archive